Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Philadelphia Chromosome Negative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05983250
What this trial is testing

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Who this might be right for
Pulmonary Hypertension
Tenax Therapeutics, Inc. 230
Not applicableStudy completedNCT04202276
What this trial is testing

The Study of Nutrition of Children and Adolescents With GERD

Who this might be right for
GERD in ChildrenGERD
Federal State Budgetary Scientific Institution 219
Not applicableStudy completedNCT02536534
What this trial is testing

Electronic Activity Level Monitoring Pilot in Pulmonary Hypertension

Who this might be right for
Hypertension, Pulmonary
Bayer 35
Not applicableStudy completedNCT02996864
What this trial is testing

Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II

Who this might be right for
Overweight and ObesityHealth BehaviorSleep Deprivation
Klein Buendel, Inc. 300
Testing effectiveness (Phase 2)Study completedNCT01256398
What this trial is testing

Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
National Cancer Institute (NCI) 66
Not applicableUnknownNCT01564836
What this trial is testing

Discontinuation Study of Imatinib in Adult CP CML Patients Who Have a Complete Molecular Response to Imatinib

Who this might be right for
Chronic Myeloid LeukemiaImatinibComplete Molecular Response
Seoul St. Mary's Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07301424
What this trial is testing

Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

Who this might be right for
Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)BCR-ABL Positive Acute Lymphoblastic Leukemia
University of Alberta 80
Not applicableStudy completedNCT05397782
What this trial is testing

Effects of Flourish on Recurrent Urinary Tract Infection

Who this might be right for
Urinary Tract Infections
Vaginal Biome Science 14
Early research (Phase 1)Looking for participantsNCT03595917
What this trial is testing

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaChronic Myeloid Leukemia (CML) in Lymphoid Blast CrisisPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL
Marlise Luskin, MD 40
Early research (Phase 1)Active Not RecruitingNCT04872790
What this trial is testing

Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia

Who this might be right for
B Acute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Mixed Phenotype Acute Leukemia+2 more
OHSU Knight Cancer Institute 20
Very early researchStudy completedNCT01184885
What this trial is testing

A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy

Who this might be right for
Lymphoid Malignancies (New or Relapsed)Acute Lymphoblastic LeukemiaBurkitt Lymphoma+3 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 7
Not applicableLooking for participantsNCT07495774
What this trial is testing

Insights Into Pediatric Pulmonary Hypertension: A Real-World Registry of Epidemiology and Outcomes

Who this might be right for
Pulmonary Hypertension
Guangdong Provincial People's Hospital 450
Testing effectiveness (Phase 2)Looking for participantsNCT07434843
What this trial is testing

PH 2 Pemigatinib in SDH-deficient GIST

Who this might be right for
SDH Gene MutationGastrointestinal Stromal Tumor
Dana-Farber Cancer Institute 24
Not applicableUnknownNCT02360384
What this trial is testing

Caecal pH as a Biomarker for Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
Wingate Institute of Neurogastroenterology 48
Not applicableUnknownNCT04725604
What this trial is testing

Real-time Soft Tissue Assessment Using a Technologically Advanced pH Monitoring System

Who this might be right for
Acute Compartment Syndrome
University of Aberdeen 150
Not applicableStudy completedNCT00481949
What this trial is testing

Assessment of Gastro-esophageal Reflux Using Endo-Flip vs Bravo

Who this might be right for
HeartburnGastro-esophageal Reflux
Guy's and St Thomas' NHS Foundation Trust 50
Not applicableUnknownNCT03797859
What this trial is testing

THRIVE Apneic Ventilation With Standardized Airway Management During General Anesthesia.

Who this might be right for
ApneaVentilation Therapy; ComplicationsRespiratory Acidosis
Rigshospitalet, Denmark 36
Testing effectiveness (Phase 2)Study completedNCT00769327
What this trial is testing

Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 129
Post-approval studies (Phase 4)Ended earlyNCT05071482
What this trial is testing

Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL

Who this might be right for
Acute Leukemia
Institute of Hematology & Blood Diseases Hospital, China 39
Large-scale testing (Phase 3)Study completedNCT01560624
What this trial is testing

Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 690
Next Page